• EN - English
  • FR - français
Parliamentary question - P-004650/2020Parliamentary question
P-004650/2020

Indemnity and civil liability clauses in Advance Purchase Agreements for potential COVID-19 vaccines

Priority question for written answer P-004650/2020
to the Commission
Rule 138
Marc Botenga (GUE/NGL)

Referring to an internal memo, the press has reported that Vaccines Europe, the European pharmaceutical industry’s vaccines lobby, has pushed the European Union for far-reaching exemptions from civil liability to protect its members from lawsuits if there are dangerous side effects from administering COVID-19 vaccines acquired through Advance Purchase Agreements. The Commission was quoted as saying that in the Advance Purchase Agreements for potential COVID-19 vaccines, it was looking for Member States to indemnify pharmaceutical companies for ‘certain liabilities’ ‘in order to compensate for such high risks taken by manufacturers [1] .’ These exemptions would thus transfer civil liability to the public.

Last updated: 28 August 2020
Legal notice - Privacy policy